44.34
price down icon0.89%   -0.40
pre-market  시장 영업 전:  46.15   1.81   +4.08%
loading
전일 마감가:
$44.74
열려 있는:
$44.82
하루 거래량:
974.68K
Relative Volume:
0.85
시가총액:
$3.51B
수익:
$900.66M
순이익/손실:
$-453.20M
주가수익비율:
-7.4646
EPS:
-5.94
순현금흐름:
$-274.19M
1주 성능:
-7.35%
1개월 성능:
-11.04%
6개월 성능:
-1.88%
1년 성능:
+30.07%
1일 변동 폭
Value
$44.15
$45.37
1주일 범위
Value
$44.15
$48.23
52주 변동 폭
Value
$29.02
$58.38

PTC 테라퓨틱스 Stock (PTCT) Company Profile

Name
명칭
Ptc Therapeutics Inc
Name
전화
(908) 222-7000
Name
주소
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ
Name
직원
939
Name
트위터
@PTCBio
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
PTCT's Discussions on Twitter

PTCT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PTCT
Ptc Therapeutics Inc
44.34 3.55B 900.66M -453.20M -274.19M -5.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

PTC 테라퓨틱스 Stock (PTCT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-17 개시 Truist Buy
2025-05-09 업그레이드 BofA Securities Neutral → Buy
2025-05-07 업그레이드 Citigroup Sell → Neutral
2025-03-11 업그레이드 BofA Securities Underperform → Neutral
2025-03-07 개시 Scotiabank Sector Perform
2024-12-13 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-12-03 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2024-10-10 재개 Raymond James Mkt Perform
2024-09-04 개시 Robert W. Baird Outperform
2024-08-26 재개 UBS Buy
2024-05-20 업그레이드 Raymond James Underperform → Mkt Perform
2023-12-19 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2023-12-08 개시 Wells Fargo Overweight
2023-10-30 업그레이드 Oppenheimer Perform → Outperform
2023-10-27 다운그레이드 Citigroup Neutral → Sell
2023-10-06 다운그레이드 Truist Buy → Hold
2023-09-18 다운그레이드 Citigroup Buy → Neutral
2023-09-15 다운그레이드 Raymond James Outperform → Underperform
2023-03-17 개시 SVB Securities Market Perform
2022-12-14 개시 Goldman Sell
2022-09-12 개시 Jefferies Buy
2022-09-09 개시 Morgan Stanley Equal-Weight
2022-09-01 개시 Citigroup Buy
2022-04-04 재개 Cantor Fitzgerald Overweight
2021-10-18 다운그레이드 BofA Securities Neutral → Underperform
2021-04-26 재개 Credit Suisse Neutral
2021-03-29 업그레이드 RBC Capital Mkts Underperform → Sector Perform
2021-02-12 다운그레이드 BofA Securities Buy → Neutral
2021-01-05 업그레이드 Citigroup Neutral → Buy
2020-11-30 다운그레이드 RBC Capital Mkts Sector Perform → Underperform
2020-10-30 다운그레이드 Citigroup Buy → Neutral
2020-10-28 개시 UBS Neutral
2020-10-07 업그레이드 JP Morgan Neutral → Overweight
2020-08-25 개시 Raymond James Outperform
2020-04-09 업그레이드 Citigroup Neutral → Buy
2020-02-20 다운그레이드 Citigroup Buy → Neutral
2020-02-20 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2019-11-12 개시 SunTrust Buy
2019-05-13 업그레이드 BofA/Merrill Neutral → Buy
2019-04-11 개시 Bernstein Outperform
2018-10-03 업그레이드 BofA/Merrill Underperform → Neutral
2018-10-01 개시 Cantor Fitzgerald Overweight
2018-07-19 개시 Credit Suisse Outperform
2018-06-18 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2018-04-04 다운그레이드 Barclays Equal Weight → Underweight
2018-01-29 재개 RBC Capital Mkts Sector Perform
2017-11-16 업그레이드 JP Morgan Underweight → Neutral
2017-10-26 다운그레이드 BofA/Merrill Neutral → Underperform
2017-10-09 다운그레이드 JP Morgan Neutral → Underweight
모두보기

PTC 테라퓨틱스 주식(PTCT)의 최신 뉴스

pulisher
03:17 AM

How did PTCT's revenue and expenses trends shift in Q4 2024 compared to previous quarters - AInvest

03:17 AM
pulisher
Jul 28, 2025

PTC Therapeutics' Sephience Approval: A $1B+ Rare Disease Opportunity Unfolding - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

FDA Approval Sparks Bullish Momentum In PTC Therapeutics — Here’s What Happened - Stocktwits

Jul 28, 2025
pulisher
Jul 28, 2025

US FDA approves PTC Therapeutics' metabolic disorder drug - Reuters

Jul 28, 2025
pulisher
Jul 28, 2025

PTC Therapeutics (PTCT) Gains FDA Approval for Sephience in Phenylketonuria - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

PTC Therapeutics Gains FDA Approval for Sephience - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

PTC Therapeutics stock soars after FDA approval of PKU treatment By Investing.com - Investing.com Canada

Jul 28, 2025
pulisher
Jul 28, 2025

PTC Therapeutics gets FDA nod for phenylketonuria treatment - Seeking Alpha

Jul 28, 2025
pulisher
Jul 28, 2025

FDA Approval Boosts PTC Therapeutics (PTCT) with Sephience Launch - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

PTC Therapeutics: Pioneering Rare Disease Innovation with Sephience and Kebilidi - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

PTC Therapeutics' Sephience™: A Game-Changer for PKU and Shareholder Value - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

FDA approves PTC Therapeutics’ Sephience for phenylketonuria treatment By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) | PTCT Stock News - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy PTC Therapeutics Inc. stockValue Investing Recommendation For Every Investor - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Breakthrough PKU Treatment: FDA Approves PTC's Sephience for All Ages and Disease Subtypes - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

Oversold Conditions For PTC Therapeutics - Nasdaq

Jul 28, 2025
pulisher
Jul 28, 2025

Cerity Partners LLC Buys New Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

What makes PTC Therapeutics Inc. stock price move sharplyExplosive earnings growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does PTC Therapeutics Inc. compare to its industry peersBreakout Stocks Recommendation With Proven Results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Leerink Partnrs Cuts Earnings Estimates for PTC Therapeutics - MarketBeat

Jul 28, 2025
pulisher
Jul 27, 2025

What institutional investors are buying PTC Therapeutics Inc. stockCapitalize on momentum-driven opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why is PTC Therapeutics Inc. stock attracting strong analyst attentionGet daily updates on market movers and shakers - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Does PTC Therapeutics Inc. stock perform well during market downturnsBuild a diversified portfolio for sustainable growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for PTC Therapeutics Inc.Breakthrough investment results - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is PTC Therapeutics Inc. Stock During Economic DownturnsLong Term Secure Gain Stocks - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in PTC Therapeutics Inc. stockDiscover stocks with massive upside potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is PTC Therapeutics Inc. stock expected to show significant growthRapid return acceleration - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Universal Beteiligungs und Servicegesellschaft mbH Buys 36,365 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 27, 2025
pulisher
Jul 26, 2025

Neo Ivy Capital Management Makes New Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 26, 2025
pulisher
Jul 26, 2025

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results - Quantisnow

Jul 26, 2025
pulisher
Jul 25, 2025

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU) - Quantisnow

Jul 25, 2025
pulisher
Jul 25, 2025

Leerink Partners Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Announces Target Price $50 - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

PTC Therapeutics Inc. Stock Analysis and ForecastUnrivaled growth potential - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Cwm LLC Buys 14,139 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 25, 2025
pulisher
Jul 25, 2025

Pinnacle Associates Ltd. Cuts Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 25, 2025
pulisher
Jul 25, 2025

Cautious Outlook on PTC Therapeutics: Sepiapterin’s Limited Potential to Offset Declining DMD Revenues - TipRanks

Jul 25, 2025
pulisher
Jul 23, 2025

PTC Therapeutics Surges to 488th in Daily Rankings with 2.35 Billion Trading Volume Despite Slight Price Decline - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

8,196 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Bought by Edgestream Partners L.P. - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Huntington's Disease Clinical, Companies, Therapeutic - openPR.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about PTC Therapeutics Inc. stockPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is PTC Therapeutics Inc. a good long term investmentExceptional market positioning - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives PTC Therapeutics Inc. stock priceRobust investment performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics - Yahoo Finance

Jul 22, 2025
pulisher
Jul 21, 2025

Pega to Announce Financial Results for the Second Quarter of 2025 and Host Conference Call and Webcast - Yahoo.co

Jul 21, 2025
pulisher
Jul 21, 2025

Pierre Gravier Sells 2,516 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock - MarketBeat

Jul 21, 2025

PTC 테라퓨틱스 (PTCT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
자본화:     |  볼륨(24시간):